Seed giants active around new methods of genetic engineering

Soaring number of patent applications including those on farm animals

Wednesday, 2 March 2016

Testbiotech has published a report which for the first time gives an overview of patents filed by large corporations for the use of gene-editing and synthetic gene technology in food plants. According to the research presented in the report, DuPont and Dow Agrosciences are the corporates that have filed the highest number of patent applications for plants derived from the new methods. They are closely followed by German company, Bayer. In addition, there is an increasing number of patents being filed for the use of these methods in farm animals.

Transgenic maize authorisation must be rescinded to prevent crossbreeding with new invasive species

Potential for genetically engineered maize to crossbreed with its wild ancestor teosinte

Thursday, 25 February 2016

Today thirteen civil society organisations active in agriculture and environmental issues have officially alerted the European Commission that the wild ancestor of cultivated maize, teosinte, has appeared in Spain and is spreading widely in maize growing areas as an invasive species. Teosinte and maize have the potential to interbreed and form hybrids. This applies equally to genetically engineered maize MON810, produced by Monsanto and grown on more than 100,000 hectares in Spain.

Diseased animals - but genetically engineered plants are safe?

New debate on the health risks of genetically engineered plants

26 January 2016 / Several new publications on the outcomes of feeding genetically engineered plants to cattle and goats have triggered a new controversial debate about the impact on the health of animals.

One new publication documents the case of a German farm where dairy cows died after being fed with genetically engineered plants (1). Although this happened about 15 years ago, the real causes are still cause for controversy. Industry continues to reject all the allegations that were made, and sees no need for further investigation.


Subscribe to testbiotech RSS